Movement disorders with tau protein cytoskeletal pathology
Jellinger, K.A.
Advances in Neurology 80: 303-311
1999
ISSN/ISBN: 0091-3952 PMID: 10410735 Document Number: 512058
Document emailed within 1 workday
Related Documents
Yumura, W.; Nitta, K.; Uchida, K.; Murai, K.; Horita, S.; Tsutsui, T.; Nihei, H. 1994: Association of cell cycle and protein kinase C with the expression of cytoskeletal protein in cultured rat mesangial cells Nihon Jinzo Gakkai Shi 36(10): 1090-1094Ho, W.C.; Storrie, B.; Pepperkok, R.; Ansorge, W.; Karecla, P.; Kreis, T.E. 1990: Movement of interphase Golgi apparatus in fused mammalian cells and its relationship to cytoskeletal elements and rearrangement of nuclei European Journal of Cell Biology 52(2): 315-327
Leigh, P.N.; Swash, M. 1991: Cytoskeletal pathology in motor neuron diseases Advances in Neurology 56: 115-124
Higashitsuji, H.; Arii, S.; Furutani, M.; Imamura, M.; Kaneko, Y.; Takenawa, J.; Nakayama, H.; Fujita, J. 1995: Enhanced expression of multiple protein tyrosine phosphatases in the regenerating mouse liver: isolation of PTP-RL10, a novel cytoplasmic-type phosphatase with sequence homology to cytoskeletal protein 4.1 Oncogene 10(2): 407-414
Guay-Woodford, L.M.; Platt, O.; Harris, H.W. 1991: Toad urinary bladder epithelial cells contain an analogue of cytoskeletal protein 4.1 American Journal of Physiology 260(6 Pt 1): C1308-C1314
Song, X.; Ehrich, M. 1998: Alterations of cytoskeletal tau protein of SH-SY5Y human neuroblastoma cells after exposure to MPTP Neurotoxicology 19(1): 73-81
Shevtsov, P.N.; Burbaeva, G.S. 1998: The pathogenesis of Alzheimer's disease: the effect of aluminum ions on the cytoskeletal protein tubulin Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 98(3): 46-47
DeCaprio, A.P. 1987: N-Hexane neurotoxicity: a mechanism involving pyrrole adduct formation in axonal cytoskeletal protein Neurotoxicology 8(1): 199-210
Cartwright, C.A.; Mamajiwalla, S.; Skolnick, S.A.; Eckhart, W.; Burgess, D.R. 1993: Intestinal crypt cells contain higher levels of cytoskeletal-associated pp60c-src protein tyrosine kinase activity than do differentiated enterocytes Oncogene 8(4): 1033-1039
Pokudin, N.I.; Orlov, S.N.; Postnov, I.V. 1986: The Ca pump and Ca ATPase in the erythrocytes of patients with hypertension: disorders detected in cytoskeletal membranes and in solubilized Ca ATPase Kardiologiia 26(3): 94-99
Vedanarayanan, V.V. 1997: Paroxysmal movement disorders Pediatric Annals 26(7): 402-408
Larsen, T.A.; Teräväinen, H. 1986: The evaluation of movement disorders Duodecim; Laaketieteellinen Aikakauskirja 102(20): 1505-1513
Vela-Desojo, L.; Vaamonde-Gamo, J.; Obeso-Insausti, J.A. 2000: Paroxysmal movement disorders Revista de Neurologia 31(1): 71-79
Søborg, P.A.; Albrechtsen, L.; Olsen, H.H.; laCour, P. 2017: Functional neurological movement disorders Ugeskrift for Laeger 179(50)
Assal, G.; Regli, F. 1983: Motor neglect: a new look at movement disorders Schweizerische Rundschau für Medizin Praxis 72(29): 987-990
Mathé, J.F.; Cler, J.M.; Venisse, J.L. 1978: Therapeutic use of tiapride in movement disorders La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 54(13-16): 517-520
Klushin, D.F. 1976: Classification of movement disorders in epilepsy Sovetskaia Meditsina 11: 18-20
Velázquez-Pérez, J.M.; Marsal-Alonso, C. 2009: Drug-induced movement disorders Revista de Neurologia 48(Suppl 1): S57-S60
Powers, J.M. 1983: Drug-induced movement disorders Arizona Medicine 40(7): 464-467
Tomita, S.; Ohmoto, T. 2000: Stereotactic neurosurgery for movement disorders No Shinkei Geka. Neurological Surgery 28(2): 107-125